Vimarsana
Biggest News Aggregation in the World

Banc Life Sciences News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Banc Life Sciences. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Banc Life Sciences Today - Breaking & Trending Today

Recursion to Participate in Upcoming Investor Conferences - Vimarsana News

Recursion to Participate in Upcoming Investor Conferences

SALT LAKE CITY, March 01, 2024 -- Recursion , a leading clinical stage TechBio company decoding biology to industrialize drug discovery, today announced its participation in the following investor...

Sotera Health Reports Fourth-Quarter and Full-Year 2023 Results; Provides 2024 Outlook - Vimarsana News

Sotera Health Reports Fourth-Quarter and Full-Year 2023 Results; Provides 2024 Outlook

2023 net revenues increased 4.5% to $1.05 billion, compared to 20222023 net income of $51 million or $0.18 per diluted share2023 Adjusted EBITDA increased 4.3% to $528 million2023 Adjusted EPS ...

Rapid Micro Biosystems to Participate in Upcoming Investor - Vimarsana News

Rapid Micro Biosystems to Participate in Upcoming Investor

LOWELL, Mass., Feb. 27, 2024 (GLOBE NEWSWIRE) -- Rapid Micro Biosystems, Inc. (Nasdaq: RPID) (the “Company”), an innovative life sciences technology...

908 Devices to Participate in Upcoming Investor Conferences - Vimarsana News

908 Devices to Participate in Upcoming Investor Conferences

908 Devices Inc. , a pioneer of purpose-built handheld and desktop devices for chemical and biochemical analysis, today announced it will participate in the following investor conferences. Cowen...

Schrödinger to Participate in Upcoming Investor Conferences - Vimarsana News

Schrödinger to Participate in Upcoming Investor Conferences

Schrödinger , whose physics-based computational platform is transforming the way therapeutics and materials are discovered, today announced that management will participate in the following...